Viktoria Laszlo
Vienna, 1090, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 77 publications
Comparative assessment of intratumoral sunitinib distribution and therapeutic response in matched primary and metastatic tumor models.
Journal: European journal of pharmacology
Published: April 29, 2026
MiR-21 Is a Novel Diagnostic and Prognostic Circulating Biomarker in Pleural Mesothelioma.
Journal: Diagnostics (Basel, Switzerland)
Published: March 03, 2026
Immune-related markers define clinically relevant prognostic subgroups in thymic epithelial tumors.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 26, 2026
High circulating activin A plasma levels are associated with tumour stage and poor survival in treatment-naive lung squamous cell cancer patients.
Journal: Translational oncology
Published: July 01, 2024
C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer.
Journal: World journal of surgical oncology
Published: August 30, 2023
Circulating FGF18 is decreased in pleural mesothelioma but not correlated with disease prognosis.
Journal: Thoracic cancer
Published: April 07, 2023
Laser ablation-inductively coupled plasma-mass spectrometry analysis reveals differences in chemotherapeutic drug distribution in surgically resected pleural mesothelioma.
Journal: British journal of clinical pharmacology
Published: January 18, 2023
Comparative expression analysis of immune-related markers in surgically resected lung neuroendocrine neoplasms.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 04, 2023
Dual targeting of BCL-2 and MCL-1 in the presence of BAX breaks venetoclax resistance in human small cell lung cancer.
Journal: British journal of cancer
Published: October 05, 2022
Last Updated: 09/26/2026